Entry |
|
Name |
Mofebutazone (INN); Monazone (TN) |
Formula |
C13H16N2O2
|
Exact mass |
232.1212
|
Mol weight |
232.28
|
Structure |

|
Class |
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01947 Anti-inflammatory drug, pyrazolone
DG01949 Anti-inflammatory drug, phenylbutazones
|
Remark |
|
Efficacy |
Analgesic, Anti-inflammatory, Antipyretic |
Comment |
Pyrazolone derivative, phenylbutazone type
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
M01AA Butylpyrazolidines
M01AA02 Mofebutazone
D07262 Mofebutazone (INN)
M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M02AA Antiinflammatory preparations, non-steroids for topical use
M02AA02 Mofebutazone
D07262 Mofebutazone (INN)
Drug groups [BR:br08330]
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01947 Anti-inflammatory drug, pyrazolone
DG01949 Anti-inflammatory drug, phenylbutazones
D07262 Mofebutazone
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 17
1 N1x N 17.2200 -14.9100
2 N1y N 17.2200 -16.3100
3 C5x C 18.5500 -16.7300
4 C1y C 19.3900 -15.6100
5 C5x C 18.5500 -14.4900
6 C1b C 20.7900 -15.6100
7 O5x O 18.9700 -18.0600
8 O5x O 18.9700 -13.1600
9 C8y C 16.0300 -17.1500
10 C8x C 16.0300 -18.5500
11 C8x C 14.8400 -19.2500
12 C8x C 13.6500 -18.5500
13 C8x C 13.6500 -17.1500
14 C8x C 14.8400 -16.4500
15 C1b C 21.4851 -14.3947
16 C1b C 22.8897 -14.3889
17 C1a C 23.5714 -13.1970
BOND 18
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 1 5 1
6 4 6 1
7 3 7 2
8 5 8 2
9 2 9 1
10 9 10 2
11 10 11 1
12 11 12 2
13 12 13 1
14 13 14 2
15 9 14 1
16 6 15 1
17 15 16 1
18 16 17 1
|